Cargando…
Prediction of sarcopenia using a combination of multiple serum biomarkers
Sarcopenia is a gradual loss of skeletal muscle mass and function with aging. Given that sarcopenia has been recognized as a disease entity, effective molecular biomarkers for early diagnosis are required. We recruited 46 normal subjects and 50 patients with moderate sarcopenia aged 60 years and old...
Autores principales: | Kwak, Ju Yeon, Hwang, Hyeoncheol, Kim, Seon-Kyu, Choi, Jeong Yi, Lee, Seung-Min, Bang, Hyun, Kwon, Eun-Soo, Lee, Kwang-Pyo, Chung, Sun Gun, Kwon, Ki-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988732/ https://www.ncbi.nlm.nih.gov/pubmed/29872072 http://dx.doi.org/10.1038/s41598-018-26617-9 |
Ejemplares similares
-
Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia
por: Kwak, Ju Yeon, et al.
Publicado: (2019) -
Molecular mechanisms and therapeutic interventions in sarcopenia
por: Park, Sung Sup, et al.
Publicado: (2017) -
Fatty acid amides as potential circulating biomarkers for sarcopenia
por: Kim, Ye An, et al.
Publicado: (2023) -
A subset of microRNAs in the Dlk1‐Dio3 cluster regulates age‐associated muscle atrophy by targeting Atrogin‐1
por: Shin, Yeo Jin, et al.
Publicado: (2020) -
Identification of novel genes associated with exercise and calorie restriction effects in skeletal muscle
por: Kang, Jae Sook, et al.
Publicado: (2023)